Showing results (251-260 of 272) with videos related to
Sort By:
Pageof 28
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 28, 2019
Apalutamide and overall survival in non-metastatic castration-resistant prostate cancerE J Small, F Saad, S Chowdhury, et al.Nature|May 6, 2026
Pollinators support the nutrition and income of vulnerable communitiesT P Timberlake, S Sapkota, N M Saville, et al.Plos One|June 9, 2025
Developing a stakeholder-informed social responsibility model for translational scienceElise M R Smith, Georgia Loutrianakis, Kimberly Beatty, et al.Molecular Cancer Research : MCR|January 13, 2023
Malignant Progression of an Ancestral Bone Marrow Clone Harboring a CIC-NUTM2A Fusion in Isolated Myeloid SarcomaJennifer L Kamens, Jinjun Dang, Timothy I Shaw, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 15, 2002
Hazard identification by methods of animal-based toxicologyS M Barlow, J B Greig, J W Bridges, et al.Environmental Toxicology and Pharmacology|July 26, 2011
Towards internationally acceptable standards for food additives and contaminants based on the use of risk analysisA Huggett, B J Petersen, R Walker, et al.Water Science and Technology : a Journal of the International Association on Water Pollution Research|October 30, 2019
Bacterial community structure and response to nitrogen amendments in Lake Shenandoah (VA, USA)G Reynoso, M R Smith, C P Holmes, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 3, 2023
Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trialK N Chi, S Sandhu, M R Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working GroupG J Bubley, M Carducci, W Dahut, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamideD E Rathkopf, M R Smith, C J Ryan, et al.Pageof 28